Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Ram Navami 2024
Dubai Rains
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Safety Monitoring Board
FOLLOW
Safety monitoring board, Latest News
Health :
Covid: Pfizer vax for 2 to 4 year-olds fails to produce expected immunity
New York, Dec 18 The Covid vaccine developed for small children aged 2 to 4-year-olds by US drug ... ...
International :
AstraZeneca revises vaccine efficacy to 76 per cent after dispute over US study
UK-Swedish drugmaker AstraZeneca on Thursday reasserted effectiveness of its vaccine after recalculating data from the disputed US study, albeit revising its efficacy in preventing symptomatic coronavirus cases down by three percentage points to 76 p ...
Health :
After snub, AstraZeneca to share latest data on US vax trials
New York, March 23 Following the doubts expressed by a top US-based health agency over the Covid-19 vaccine ... ...
National :
Russian COVID vaccine Sputnik V meets primary safety endpoint in phase-2 clinical trials in India
The Russian made Covid-19 vaccine Sputnik V has met the primary endpoint of safety in the phase-2 clinical trials in India and has been recommended to continue the clinical trial without any modifications, according to an official statement. ...